Showing 1 - 10 of 190
Oped, Postbag, Published on 26/03/2026
» Re: "MFA proposes slashing visa-free tourist period in half", (BP, March 25) & "Explainer: Thailand's new visas", (Podcast, Aug 5, 2024).
Oped, Postbag, Published on 24/03/2026
» Re: "30-day visa-free stay 'sufficient', says minister", (BP, March 21) & "Thailand reviewing visa-free stays as local complaints pile up" & "Phuket up in arms on long‑stay visa", (BP, March 18).
Oped, Editorial, Published on 20/02/2026
» After months of suffering in silence, businesses along the Thai-Cambodian border are finally starting to speak up, saying the security measures implemented in the wake of the armed clashes between the two countries -- including border closures -- have dealt a heavy blow to their livelihoods.
Oped, Yurdi Yasmi, Published on 22/01/2026
» With the world struggling to feed eight billion people today, how will we feed ten billion by 2050?
Oped, Saritdet Marukatat, Published on 24/12/2025
» 2025 was a big loss for all interprovincial bus operators as it was the end of the road for a woman who staunchly protected their business.
Oped, Anna Kofoed, Published on 12/12/2025
» In our increasingly turbulent world, travelling for many no longer unfolds as a straightforward endeavour.
Oped, Thitinan Pongsudhirak, Published on 07/11/2025
» Storming through Asia last week, US President Donald Trump's first stop in Kuala Lumpur on Oct 26, before moving on to Japan and South Korea over the next four days, capped by his meeting with Chinese President Xi Jinping before returning to Washington, was the most consequential for Southeast Asian economies.
Oped, Postbag, Published on 21/10/2025
» Re: "Populism takes priority", (BP, Oct 18).
Oped, Peter Singer & Sankalpa Ghose, Published on 17/10/2025
» Even in an era of intense political polarisation, there are still moments when a bipartisan consensus can emerge around important ethical issues. One such moment is happening now. Last April, the United States Food and Drug Administration released its "Roadmap to Reducing Animal Testing in Preclinical Safety Studies". The FDA said that it was taking "a groundbreaking step" that would advance public health and limit wasteful expenditure by replacing animal testing with "more effective, human-relevant methods".